The importance of genes implicated in DNA damage response or repair pathways in tumor development was highlighted in the 1990s by two research groups that found an increased susceptibility to inherited breast cancer (BC) and ovarian cancer (OC) in patients harboring germline mutations of BRCA1 and BRCA2 genes [2,3]. This evidence concerns the gene BRCA1 and breast cancer.